Hematology/Oncology Clinics of North America

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Hematology/Oncology Clinics of North America is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1558-1977 · 0889-8588
Country
United States
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1987-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3812

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

122

i10-index

1967

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
68%
ORCID iDs in current deposits
0%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
8709473
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
Show all subjects (50)
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Blood groups and transfusion
  • Lung Cancer Treatments and Mutations
  • Blood groups and transfusion
  • Legal case studies and regulations
  • Legal case studies and regulations
  • Multiple Myeloma Research and Treatments
  • Legal Cases and Commentary
  • Multiple Myeloma Research and Treatments
  • Legal Cases and Commentary
  • Sarcoma Diagnosis and Treatment
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Sarcoma Diagnosis and Treatment
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood Coagulation and Thrombosis Mechanisms
  • Cancer Genomics and Diagnostics
  • CNS Lymphoma Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
  • Cancer Genomics and Diagnostics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: